Inicio › Diabetes tipo 2 › South Carolina

Ensayos clínicos de Diabetes tipo 2 en South Carolina

19 estudios sobre Diabetes tipo 2 buscan participantes en South Carolina.

Ciudades en South Carolina

Texto oficial del estudio (inglés)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

PanAmerican Clinical Research - Bluffton, Bluffton

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Piedmont Research Partners, LLC, Fort Mill
Velocity Clinical Research-Gaffney-69046, Gaffney
Tribe Clinical Research LLC - Greenville, Greenville
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Coastal Carolina Research Center, North Charleston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Accellacare - Mt Pleasant, Mt. Pleasant

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Monroe Biomedical Research - Charleston, North Charleston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Myrtle Beach
Research Site, North Charleston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07662213

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Monroe Biomedical Research, LLC, North Charleston

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 7 oct 2026 · NCT07668388

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Velocity Clinical Research, Anderson, Anderson
Accellacare Charleston, Mt. Pleasant

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT07296484

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Medical University of South Carolina, Charleston

ReclutandoSe aceptan voluntarios sanos

Edades de 55 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06112418

Improving the Collaborative Health of Adult Dyads

University of South Carolina, Columbia

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT05370014

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Bluffton
AURORA-2 Clinical Site, Clemson
AURORA-2 Clinical Site, Columbia
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, Gaffney
Research Site, Greenville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Piedmont Research Partners, LLC, Fort Mill
Accellacare US Inc._SC, Mt. Pleasant
Trial Management Associates, Myrtle Beach

ReclutandoFase 3

Edades de 45 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site, Anderson

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Research Site, Gaffney

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT07606066

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

Clemson Health Clinic at Orangeburg, Orangeburg
Clemson Health Clinic at Walhalla, Walhalla

ReclutandoEstudio observacionalSe aceptan voluntarios sanosIndica pago para participantes

Edades de 40 a 70 · Todos los sexos · Actualizado el 18 ago 2026 · NCT07731399

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Prisma Health Pediatric Endocrinology, Columbia
Prisma Health Midlands, Greenville

ReclutandoFase 3

Edades de 10 a 17 · Todos los sexos · Actualizado el 7 ago 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Research Site, Myrtle Beach

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT07664553

CGM for Management of Type 2 Diabetes in Pregnancy

Prisma Health Greenville Memorial Hospital, Greenville

Reclutando

Edades de 18 a 50 · Mujeres · Actualizado el 29 jun 2026 · NCT06628453

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.